But patients with upgrading showed significantly higher PSA density (P < 0.001), longer tumor length in biopsy core (P < 0.001), and higher number of positive biopsy cores (P < 0.001) than the patients without upgrading. The gene discussed is KLK3; the disease is neoplasm.